Spots Global Cancer Trial Database for bavituximab
Every month we try and update this database with for bavituximab cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study of Pembrolizumab and Bavituximab in Patients With Advanced Hepatocellular Carcinoma | NCT03519997 | Hepatocellular ... | Pembrolizumab Bavituximab | 18 Years - | University of Texas Southwestern Medical Center | |
| Safety and Efficacy Study of Bavituximab Plus Paclitaxel and Carboplatin to Treat Breast Cancer | NCT00669565 | Carcinoma Breas... | Bavituximab | 18 Years - | Peregrine Pharmaceuticals | |
| Ph Ib/IIa Study of Cabazitaxel Plus Bavituximab in Castration-resistant Prostate Cancer | NCT01335204 | Prostate Cancer Prostatic Neopl... | Cabazitaxel plu... | 18 Years - | Medical University of South Carolina | |
| A Study of Neoadjuvant Paclitaxel in Combination With Bavituximab in Early- Stage Triple- Negative Breast Cancer | NCT02685306 | Breast Cancer Triple Negative... Triple-Negative... Triple-Negative... Triple Negative... ER-Negative PR-... ER-Negative PR-... | Bavituximab Taxane | 18 Years - | Peregrine Pharmaceuticals | |
| Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular Carcinoma | NCT02989870 | HepatoCellular ... Unresectable He... Liver Cancer | Stereotactic Bo... Sorafenib Bavituximab | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Paclitaxel and Bavituximab in Treating Patients With HER2-Negative Metastatic Breast Cancer | NCT01288261 | Human Epidermal... Male Breast Can... Recurrent Breas... Stage IIIC Brea... Stage IV Breast... | paclitaxel bavituximab laboratory biom... pharmacological... | 18 Years - | University of Arizona | |
| Taxane Therapy With or Without Bavituximab for the Treatment of HER2-Negative Metastatic Breast Cancer | NCT02651610 | Metastatic Brea... | Bavituximab Taxane | 18 Years - | Peregrine Pharmaceuticals | |
| Phase 3 Study of Bavituximab Plus Docetaxel Versus Docetaxel Alone in Patients With Late-stage Non-squamous Non-small-cell Lung Cancer | NCT01999673 | Non-Small-Cell ... Non-Small-Cell ... Non-Small-Cell ... Carcinoma, Non-... Non-Small Cell ... Non-Small-Cell ... Nonsmall Cell L... | bavituximab Docetaxel Placebo (for ba... | 18 Years - | Peregrine Pharmaceuticals | |
| Bavituximab Plus Carbo and Pemetrexed in Chemo-Naive Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Subjects | NCT01323062 | Non Small Cell ... | Bavituximab | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| A Study of Neoadjuvant Paclitaxel in Combination With Bavituximab in Early- Stage Triple- Negative Breast Cancer | NCT02685306 | Breast Cancer Triple Negative... Triple-Negative... Triple-Negative... Triple Negative... ER-Negative PR-... ER-Negative PR-... | Bavituximab Taxane | 18 Years - | Peregrine Pharmaceuticals | |
| Paclitaxel and Bavituximab in Treating Patients With HER2-Negative Metastatic Breast Cancer | NCT01288261 | Human Epidermal... Male Breast Can... Recurrent Breas... Stage IIIC Brea... Stage IV Breast... | paclitaxel bavituximab laboratory biom... pharmacological... | 18 Years - | University of Arizona | |
| 1922GCCC: Pembro and Bavituximab for Squamous Cell Carcinoma of Head and Neck | NCT04150900 | Squamous Cell C... | Bavituximab Pembrolizumab | 18 Years - | University of Maryland, Baltimore | |
| Bavituximab Plus Carbo and Pemetrexed in Chemo-Naive Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Subjects | NCT01323062 | Non Small Cell ... | Bavituximab | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| A Phase I Study of Bavituximab, Capecitabine, and Radiation for the Treatment of Rectal Adenocarcinoma | NCT01634685 | Rectal Adenocar... | Radiation Bavituximab Capecitabine | 18 Years - 99 Years | University of Texas Southwestern Medical Center | |
| Ph Ib/IIa Study of Cabazitaxel Plus Bavituximab in Castration-resistant Prostate Cancer | NCT01335204 | Prostate Cancer Prostatic Neopl... | Cabazitaxel plu... | 18 Years - | Medical University of South Carolina | |
| Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer | NCT01272791 | Metastatic Panc... | bavituximab Gemcitabine | 18 Years - | Peregrine Pharmaceuticals |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
